Envoy Medical Hits 12-Month Milestone For First Wave Of Cochlear Implant Trial

Envoy Medical has reached a significant milestone with the first three patients from its cochlear implant trial completing their 12-month follow-up evaluations. The trial's primary endpoints are linked to this 12-month data, and upon completion of evaluations for all participants, Envoy Medical intends to submit a Premarket Approval (PMA) application to the U.S. FDA.